MARYELLEN LANGLEY: Open Payments
NPI 1386027373 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 52 payments from 8 companies in 2025. Trend: 2023 $871 · 2024 $637 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 20 | $365 |
| Indivior Inc. | 19 | $198 |
| ABBVIE INC. | 4 | $74 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Lundbeck LLC | 2 | $34 |
| Braeburn Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
Products named: UZEDY, SUBLOCADE, AUSTEDO XR, VRAYLAR, COBENFY, REXULTI, BRIXADI, CAPLYTA.
Industry payments across UT — which companies pay providers there.
